Zur klinischen Anwendung von Ginkgo biloba bei dementiellen Syndromen. (Hirnleistungsstörungen bei vasculärer oder degenerativer ZNS‐Erkrankung)
- 1 January 1992
- journal article
- review article
- Published by Wiley in Pharmazie in unserer Zeit
- Vol. 21 (6) , 266-275
- https://doi.org/10.1002/pauz.19920210609
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Effects of an extract of Ginkgo biloba on learning and memory in micePharmacology Biochemistry and Behavior, 1991
- Effects of an extract of Ginkgo Biloba (EGB 761) on “learned helplessness” and other models of stress in rodentsPharmacology Biochemistry and Behavior, 1990
- New experimental model for the evaluation of adaptogenic productsJournal of Ethnopharmacology, 1990
- PAF Antagonist Ginkgolide B Reduces Postischemic Neuronal Damage in Rat Brain HippocampusJournal of Cerebral Blood Flow & Metabolism, 1990
- Superoxide anion scavenging effect and superoxide dismutase activity ofGinkgo biloba extractCellular and Molecular Life Sciences, 1989
- Effects of ginkgo biloba constituents related to protection against brain damage caused by hypoxiaPharmacological Research Communications, 1988
- Influence of an extract of Ginkgo biloba on cerebral blood flow and metabolismLife Sciences, 1986
- Stimulation of astrocytes affects cytotoxic brain edemaActa Neuropathologica, 1986
- New studies on EDRF, PAF-acether, LDL, aldehydes - relation to the mechanism of atherosclerosisTrends in Pharmacological Sciences, 1985
- BN 52021 and related compounds: A new series of highly specific PAF-acether receptor antagonists isolated from Ginkgo biloba L.Blood & Vessel, 1985